| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA615274 | F | In vitro cytotoxic concentration required to inhibit hepatitisB virus (HBV) replication in 2.2.15 cell line | Homo sapiens | 18 | ALA1137080 | cell-based format | Scientific Literature | |
| 2. | ALA615275 | F | 50% Effective concentration of compound required for inhibiting intracellular viral replicative intermediate DNA in HBV-transfected 2.2.15 cell line. | Homo sapiens | 1 | ALA1130413 | cell-based format | Scientific Literature | |
| 3. | ALA615276 | F | Antiviral activity against Hepatitis B virus in 2.2.15 cell line | Homo sapiens | 6 | ALA1129120 | cell-based format | Scientific Literature | |
| 4. | ALA615277 | F | In vitro effective concentration against hepatitis B virus was determined in 2.2.15 cells | Homo sapiens | 3 | ALA1130145 | cell-based format | Scientific Literature | |
| 5. | ALA615326 | F | In vitro effective concentration against hepatitis B virus was determined in 2.2.15 cells; Not determined | Homo sapiens | 2 | ALA1130145 | cell-based format | Scientific Literature | |
| 6. | ALA884519 | F | Ability to inhibit the episomal HBV-DNA in 2.2.15 cells. | Homo sapiens | 4 | ALA1128451 | cell-based format | Scientific Literature | |
| 7. | ALA615327 | F | Concentration required to inhibit 50% of 2.2.15 cell line | Homo sapiens | 6 | ALA1129120 | cell-based format | Scientific Literature | |
| 8. | ALA615328 | A | Anti viral activity against 2.2.15 cells (concentration required to reduce the log phase cell growth by 50%). | Homo sapiens | 4 | ALA1128451 | cell-based format | Scientific Literature | |
| 9. | ALA615341 | F | Antiviral activity against HBV was determined in 2.215 cell line | Homo sapiens | 3 | ALA1131337 | cell-based format | Scientific Literature | |
| 10. | ALA615358 | F | Concentration required to inhibit 50% of extracellular circular replication of HBV DNA using 2215 cell line | Homo sapiens | 6 | ALA1129064 | cell-based format | Scientific Literature | |
| 11. | ALA827086 | F | Concentration required to inhibit 50% of intracellular circular replication of HBV DNA using 2215 cell line | Homo sapiens | 5 | ALA1129064 | cell-based format | Scientific Literature | |
| 12. | ALA688220 | F | Effective concentration required for stimulation of glucose utilization in Hepatocytes (HEP-G2 cells) | Homo sapiens | 1 | ALA1148327 | cell-based format | Scientific Literature | |
| 13. | ALA688221 | F | Maximum effect on glucose utilization in HepG2 cells expressed as % of full stimulation | Homo sapiens | 1 | ALA1148327 | cell-based format | Scientific Literature | |
| 14. | ALA884224 | F | Effective concentration required for stimulation of glucose utilization in Hepatocytes (HEP-G2 cells) | Rattus norvegicus | 1 | ALA1148327 | cell-based format | Scientific Literature | |
| 15. | ALA688222 | F | Maximum effect on glucose utilization in HepG2 cells expressed as % of full stimulation | Rattus norvegicus | 1 | ALA1148327 | cell-based format | Scientific Literature | |
| 16. | ALA688223 | F | Tested for ability to inhibit incorporation of [14C]acetate into cholesterol in cultured human hepatoma (HEP-G2) cells; 0.0071-23 | Homo sapiens | 1 | ALA1126959 | cell-based format | Scientific Literature | |
| 17. | ALA688224 | F | Tested for ability to inhibit incorporation of [14C]acetate into cholesterol in cultured human hepatoma (HEP-G2) cells; 0.013-0.81 | Homo sapiens | 1 | ALA1126959 | cell-based format | Scientific Literature | |
| 18. | ALA688225 | F | Tested for ability to inhibit incorporation of [14C]acetate into cholesterol in cultured human hepatoma (HEP-G2) cells; 0.019-0.14 | Homo sapiens | 1 | ALA1126959 | cell-based format | Scientific Literature | |
| 19. | ALA871945 | F | Tested for ability to inhibit incorporation of [14C]acetate into cholesterol in cultured human hepatoma (HEP-G2) cells; 0.046-0.17 | Homo sapiens | 1 | ALA1126959 | cell-based format | Scientific Literature | |
| 20. | ALA686028 | F | Tested for ability to inhibit incorporation of [14C]acetate into cholesterol in cultured human hepatoma (HEP-G2) cells; 0.051-0.12 | Homo sapiens | 1 | ALA1126959 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!